NCT07256015 2025-12-01Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in ItalyBristol-Myers SquibbRecruiting200 enrolled
NCT05796245 2025-06-04A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or PsoriasisPfizerCompleted2,207 enrolled 10 charts
NCT06952465 2025-05-01A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With PsoriasisBristol-Myers SquibbActive not recruiting2,000 enrolled
NCT05635266 2024-05-07Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesSanguine BiosciencesRecruiting20,000 enrolled
NCT01126619 2012-10-25A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe PsoriasisAbbottCompleted103 enrolled 18 charts